Picture of Modulight Oyj logo

MODU — Modulight Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Finland's Modulight Q3 revenue rises, order intake jumps

Finland's Modulight Q3 revenue rises, order intake jumps


Overview

  • Finland life science laser device maker's Q3 revenue grew 7% yr/yr to EUR 1.9 mln

  • EBITDA rose sharply to EUR 1.0 mln, with margin at 53.2%

  • Order intake surged 154% yr/yr, driven by increased product sales


Outlook

  • Modulight maintains 2026 outlook for increased revenue and profitability versus prior year

  • Company says macroeconomic and geopolitical uncertainty continues to impact market development and revenue

  • Modulight expects quarterly fluctuations to continue but sees improved long-term growth visibility


Result Drivers

  • PPT BUSINESS MODEL - Co said triple-digit growth in Pay Per Treatment sales and pricing changes supported improved profitability

  • PRODUCT SALES MIX - Larger share of orders in Q3 came from product sales rather than product development projects or NRE work

  • OPERATIONAL EFFICIENCY - Co attributed improved profitability to increased operational efficiency and an improved cost structure


Company press release: ID:nMFN9rsvv7


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

EUR 1.89 mln

Q3 Loss Per Share

EUR 0.01

Q3 Net Loss

EUR 395,000

Q3 EBIT

-EUR 393,000

Q3 EBITDA

EUR 1.003 mln

Q3 Free Cash Flow From Operating Activities

EUR 241,000


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Modulight Oyj is €1.20, about 26.3% above its October 22 closing price of €0.95


Reuters Recommended Reads

  • Oct 23 - Finland's Kemira Q3 revenue rises on acquisitions

  • Oct 22 - Finland's Olvi Q3 sales and profit miss estimates on soft demand

  • Oct 22 - Sweden's Sedana Medical Q3 sales rise as growth returns


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Modulight Oyj

See all news